TestBankForClayton’sBasicPharmacologyforNurses19th
Edition
ByMichelleJ.Willihnganz,SamuelL.Gurevitz,BruceClayton
Complete
,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz:
Clayton’s Basic Pharmacology for Nurses, 19th Edition
MULTIPLE CHOICE
1. Which name identifies avdrug listed bythe US Food and
Drug Administration (FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C
The official name is the name under whichva drug is listed by
the FDA. The brand name, or trademark, is the namevgiven t
o a drug by its manufacturer. The nonproprietary, or generic,
name is provided by the United States Adopted Names Coun
cil.
DIF: Cognitive Level: Knowledge REF: p. 9
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment TOP: Nursing Process Step: Assessment
CON:
Patient Education
2. Which source contains information specific to nutritional supplements?
a. USPDictionary of USAN &International Drug Names
b. Natural Medicines Comprehensive Database
c. United States Pharmacopoeia/National Formulary(USPNF)
d. Drug Interaction Facts
ANS: C
United States Pharmacopoeia/National Formulary contains information specific to nutritional s
upplements. USP Dictionaryvof USAN & International Drug Names is a compilation of drug na
mes, pronunciation guide, and possible future FDA approved drugs; it does not include nutritio
nal supplements. Natural Medicines Comprehensive Database contains
evidence-
based information on herbal medicines and herbal combination products; it does not include inf
ormation specific to nutritional supplements. Drug Interaction Facts contains comprehensive i
nformation on drug interaction facts; it does not includevnutritional supplements.
DIF: Cognitive Level: Knowledge REF: p. 4
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integ
rity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
a. Drug Facts and Comparisons
,Tests2Banks2ForvClayton’ss2Basics2PharmacologyvforvNursess219ths2E 3
dition
b. Drug Interaction Facts
c. Handbook on Injectable Drugs
d. Martindale—The Complete Drug Reference
ANS: A
Drug Facts and Comparisons contains drug monographs that describevall drugs in a th
erapeutic class. Monographs are formatted as tables to allow comparison of similar pro
ducts, brand names, manufacturers, cost indices, and available dosage forms Onlinevve
rsionvis available.
DIF: Cognitive Level: Knowledge REF: p. 4vTable 1.2
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
4. Which drug reference contains monographs aboutvvirtually everysingle-
entitydrug available in thevUnited States and describes therapeutic uses of drugs, including ap
proved and unapproved uses?
a. Martindale: The Complete Drug Reference
b. AHFS Drug Information
c. Drug Reference
d. Drug Facts andvComparisons
ANS: B
AHFS Drug Information contains monographs about virtually every single-
entity drug available in the United States and describes therapeutic uses of drugs, including appr
oved and unapproved uses.
DIF: Cognitive Level: Knowledge REF: p. 4vTable 1.2
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Planning CON: Safety | Patient Education | Clinical Judgment
5. Which online drug reference makes available to healthcare providers and the public a stand
ard, comprehensive, up-to-date look up and downloadable resource about medicines?
a. American Drug Index
b. American Hospital Formulary
c. DailyMed
d. Drug Reference
ANS: C
DailyMed makes available to healthcare providers and the public a standard, comprehensive,
up-to-
date look up and downloadable resource about medicines. The American Drug Index is not app
ropriate for patient use. The American Hospital Formulary is not appropriate for patient use.
The drug reference is not appropriate for patient use.
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integ
rity
TOP: Nursing Process Step: Implementation
CON: Safety | Patient Education | Clinical Judgment
6. Which legislation authorizes the FDA to determine the safetyof a drug before its marketing?
a. Federal Food, Drug, and Cosmetic Act (1938)
b. Durham Humphrey Amendment (1952)
, Tests2Banks2ForvClayton’ss2Basics2PharmacologyvforvNursess219ths2E 4
dition
c. Controlleds2Substancess2Acts2(1970)
d. Kefauvers2Harriss2Drugs2Amendments2(1962)
ANS:s2A
Thes2Federals2Food,s2Drug,s2ands2Cosmetics2Actvofs21938s2authorizeds2thes2FDAs2tos2determin
evthes2safets2ys2ofs2alls2drugsvbefores2marketing.s2Laters2amendmentss2ands2actss2helpeds2tightens
2FDAs2controls2ands2ens2surevdrugs2safety.s2Thes2Durhams2Humphreys2Amendments2definess2the
s2kindss2ofs2drugss2thats2cannots2bes2useds2safelys2withouts2medicals2supervisions2ands2restrictss2
theirs2sales2tos2prescriptions2bys2as2licenseds2prs2actitioner.s2Thes2Controlleds2Substancess2Acts2a
ddressess2onlys2controlleds2substancess2ands2theirs2categos2rization.s2Thes2Kefauvers2Harriss2Dru
gs2Amendments2ensuress2drugvefficacys2ands2greaters2drugs2safety.s2Drugs2manufacturerss2ares2r
equireds2tos2provevtos2thevFDAs2thes2effectivenesss2ofs2theirs2productss2befores2marketings2them.
DIF: Cognitives2Level:s2Knowledge
REF:s 2 p.s25s2Tables2l.3s2OBJ:s 2 5
NAT:s2NCLEXs2Clients2Needss2Category:s2Physiologicals2Integ
ritys2TOP:s 2 Nursings2Processs2Step:s2Assessment
CON:s 2 Safetys2|s2Patients2Educations2|s2Evidences2|s2Healths2Cares2Law
7. Whichs2classifications2doess2meperidines2(Demerol)s2 falls2under?
a. I
b. II
c. III
d. IV
ANS:s2B
Meperidines2(Demerol)s2iss2as2Schedules2IIs2drug;s2its2hass2as2highs2potentials2fors2abuses2ands2ma
ys2leads2tos2ses2veres2psychologicals2ands2physicals2dependence.s2Schedules2Is2drugss2haves2highs2
potentials2fors2abuses2ands2nos2recognizeds2medicals2use.s2Schedules2IIIs2drugss2havevsomes2pot
entials2fors2abuse.s2Uses2mays2leads2tos2lows2tos2moderates2physicals2dependences2ors2highs2psyc
hologicals2dependence.s2SchedulevIVs2drugss2has2ves2lows2potentials2fors2abuse.s2Uses2mays2lea
ds2tos2limiteds2physicals2ors2psychologicals2dependence.
DIF:s 2 s 2 Cognitives2Level:s2Knowledge REF:s 2 p.s210
OBJ:s22s2NAT:s2 NCLEXs2Clients2Needss2Category:s2Safe,s2Effecti
ves2Cars2es2Environment
TOP:s 2 Nursings2Processs2Step:s2Assessments 2 s 2 CON:s 2 PatientvEducations2|s2Addictions2|s2Pain
8. Whichs2actions2woulds2thes2FDAs2takes2tovexpedites2drugvdevelopments2ands2approvals2fors2ans2ou
tbreaks2os2fs2smallpox?
a. Lists2smallpoxs2ass2as2healths2orphans2disease.
b. Omits2thes2preclinicals2researchs2phase.
c. Extendvthes2clinicals2researchs2phase.
d. Fasts2tracks2thes2investigationals2drug.
ANS:s2D
Onces2thes2Investigationals2News2Drugs2Applications2hass2beens2approved,s2thes2drugs2cans2rec
eives2highs2ests2prioritys2withins2thevagency,s2whichs2iss2calleds2fasts2tracking.s2As2smallpoxs2
outbreaks2woulds2becos2mes2as2prioritys2concerns2ins2thes2world.s2Orphans2diseasess2ares2nots2re
searcheds2ins2as2prioritys2manner.s2Prs2eclinicals2researchs2iss2nots2omitted.s2Extendingvanys2phas
es2ofs2thes2researchs2woulds2means2as2longers2tims2es2tos2develops2as2vaccine.s2Thes2FDAs2musts2en
sures2thats2alls2phasess2ofs2thes2preclinicals2ands2clinicals2reseas2rchs2phasevhaves2beens2complete
ds2ins2as2safes2manner.
DIF: Cognitives2Level:s2Knowledge REF:s 2 p.s27 OBJ:s25
Edition
ByMichelleJ.Willihnganz,SamuelL.Gurevitz,BruceClayton
Complete
,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz:
Clayton’s Basic Pharmacology for Nurses, 19th Edition
MULTIPLE CHOICE
1. Which name identifies avdrug listed bythe US Food and
Drug Administration (FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C
The official name is the name under whichva drug is listed by
the FDA. The brand name, or trademark, is the namevgiven t
o a drug by its manufacturer. The nonproprietary, or generic,
name is provided by the United States Adopted Names Coun
cil.
DIF: Cognitive Level: Knowledge REF: p. 9
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment TOP: Nursing Process Step: Assessment
CON:
Patient Education
2. Which source contains information specific to nutritional supplements?
a. USPDictionary of USAN &International Drug Names
b. Natural Medicines Comprehensive Database
c. United States Pharmacopoeia/National Formulary(USPNF)
d. Drug Interaction Facts
ANS: C
United States Pharmacopoeia/National Formulary contains information specific to nutritional s
upplements. USP Dictionaryvof USAN & International Drug Names is a compilation of drug na
mes, pronunciation guide, and possible future FDA approved drugs; it does not include nutritio
nal supplements. Natural Medicines Comprehensive Database contains
evidence-
based information on herbal medicines and herbal combination products; it does not include inf
ormation specific to nutritional supplements. Drug Interaction Facts contains comprehensive i
nformation on drug interaction facts; it does not includevnutritional supplements.
DIF: Cognitive Level: Knowledge REF: p. 4
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integ
rity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
a. Drug Facts and Comparisons
,Tests2Banks2ForvClayton’ss2Basics2PharmacologyvforvNursess219ths2E 3
dition
b. Drug Interaction Facts
c. Handbook on Injectable Drugs
d. Martindale—The Complete Drug Reference
ANS: A
Drug Facts and Comparisons contains drug monographs that describevall drugs in a th
erapeutic class. Monographs are formatted as tables to allow comparison of similar pro
ducts, brand names, manufacturers, cost indices, and available dosage forms Onlinevve
rsionvis available.
DIF: Cognitive Level: Knowledge REF: p. 4vTable 1.2
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
4. Which drug reference contains monographs aboutvvirtually everysingle-
entitydrug available in thevUnited States and describes therapeutic uses of drugs, including ap
proved and unapproved uses?
a. Martindale: The Complete Drug Reference
b. AHFS Drug Information
c. Drug Reference
d. Drug Facts andvComparisons
ANS: B
AHFS Drug Information contains monographs about virtually every single-
entity drug available in the United States and describes therapeutic uses of drugs, including appr
oved and unapproved uses.
DIF: Cognitive Level: Knowledge REF: p. 4vTable 1.2
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Planning CON: Safety | Patient Education | Clinical Judgment
5. Which online drug reference makes available to healthcare providers and the public a stand
ard, comprehensive, up-to-date look up and downloadable resource about medicines?
a. American Drug Index
b. American Hospital Formulary
c. DailyMed
d. Drug Reference
ANS: C
DailyMed makes available to healthcare providers and the public a standard, comprehensive,
up-to-
date look up and downloadable resource about medicines. The American Drug Index is not app
ropriate for patient use. The American Hospital Formulary is not appropriate for patient use.
The drug reference is not appropriate for patient use.
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integ
rity
TOP: Nursing Process Step: Implementation
CON: Safety | Patient Education | Clinical Judgment
6. Which legislation authorizes the FDA to determine the safetyof a drug before its marketing?
a. Federal Food, Drug, and Cosmetic Act (1938)
b. Durham Humphrey Amendment (1952)
, Tests2Banks2ForvClayton’ss2Basics2PharmacologyvforvNursess219ths2E 4
dition
c. Controlleds2Substancess2Acts2(1970)
d. Kefauvers2Harriss2Drugs2Amendments2(1962)
ANS:s2A
Thes2Federals2Food,s2Drug,s2ands2Cosmetics2Actvofs21938s2authorizeds2thes2FDAs2tos2determin
evthes2safets2ys2ofs2alls2drugsvbefores2marketing.s2Laters2amendmentss2ands2actss2helpeds2tightens
2FDAs2controls2ands2ens2surevdrugs2safety.s2Thes2Durhams2Humphreys2Amendments2definess2the
s2kindss2ofs2drugss2thats2cannots2bes2useds2safelys2withouts2medicals2supervisions2ands2restrictss2
theirs2sales2tos2prescriptions2bys2as2licenseds2prs2actitioner.s2Thes2Controlleds2Substancess2Acts2a
ddressess2onlys2controlleds2substancess2ands2theirs2categos2rization.s2Thes2Kefauvers2Harriss2Dru
gs2Amendments2ensuress2drugvefficacys2ands2greaters2drugs2safety.s2Drugs2manufacturerss2ares2r
equireds2tos2provevtos2thevFDAs2thes2effectivenesss2ofs2theirs2productss2befores2marketings2them.
DIF: Cognitives2Level:s2Knowledge
REF:s 2 p.s25s2Tables2l.3s2OBJ:s 2 5
NAT:s2NCLEXs2Clients2Needss2Category:s2Physiologicals2Integ
ritys2TOP:s 2 Nursings2Processs2Step:s2Assessment
CON:s 2 Safetys2|s2Patients2Educations2|s2Evidences2|s2Healths2Cares2Law
7. Whichs2classifications2doess2meperidines2(Demerol)s2 falls2under?
a. I
b. II
c. III
d. IV
ANS:s2B
Meperidines2(Demerol)s2iss2as2Schedules2IIs2drug;s2its2hass2as2highs2potentials2fors2abuses2ands2ma
ys2leads2tos2ses2veres2psychologicals2ands2physicals2dependence.s2Schedules2Is2drugss2haves2highs2
potentials2fors2abuses2ands2nos2recognizeds2medicals2use.s2Schedules2IIIs2drugss2havevsomes2pot
entials2fors2abuse.s2Uses2mays2leads2tos2lows2tos2moderates2physicals2dependences2ors2highs2psyc
hologicals2dependence.s2SchedulevIVs2drugss2has2ves2lows2potentials2fors2abuse.s2Uses2mays2lea
ds2tos2limiteds2physicals2ors2psychologicals2dependence.
DIF:s 2 s 2 Cognitives2Level:s2Knowledge REF:s 2 p.s210
OBJ:s22s2NAT:s2 NCLEXs2Clients2Needss2Category:s2Safe,s2Effecti
ves2Cars2es2Environment
TOP:s 2 Nursings2Processs2Step:s2Assessments 2 s 2 CON:s 2 PatientvEducations2|s2Addictions2|s2Pain
8. Whichs2actions2woulds2thes2FDAs2takes2tovexpedites2drugvdevelopments2ands2approvals2fors2ans2ou
tbreaks2os2fs2smallpox?
a. Lists2smallpoxs2ass2as2healths2orphans2disease.
b. Omits2thes2preclinicals2researchs2phase.
c. Extendvthes2clinicals2researchs2phase.
d. Fasts2tracks2thes2investigationals2drug.
ANS:s2D
Onces2thes2Investigationals2News2Drugs2Applications2hass2beens2approved,s2thes2drugs2cans2rec
eives2highs2ests2prioritys2withins2thevagency,s2whichs2iss2calleds2fasts2tracking.s2As2smallpoxs2
outbreaks2woulds2becos2mes2as2prioritys2concerns2ins2thes2world.s2Orphans2diseasess2ares2nots2re
searcheds2ins2as2prioritys2manner.s2Prs2eclinicals2researchs2iss2nots2omitted.s2Extendingvanys2phas
es2ofs2thes2researchs2woulds2means2as2longers2tims2es2tos2develops2as2vaccine.s2Thes2FDAs2musts2en
sures2thats2alls2phasess2ofs2thes2preclinicals2ands2clinicals2reseas2rchs2phasevhaves2beens2complete
ds2ins2as2safes2manner.
DIF: Cognitives2Level:s2Knowledge REF:s 2 p.s27 OBJ:s25
